Kempegowda Institute of Medical Sciences Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT01095640
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kempegowda Institute of Medical Sciences, Bangalore

Active Ingredients

Drugs in Phase 4 Trials (1)

acetaminophen (tylenol) (1 trial)

Drugs in Other Trials (3)

adapalene (differin) (1 trial)

clindamycin (cleocin) (1 trial)

tretinoin (Retin-A) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4